Integrin β4 is a controversial target for non–small cell lung cancer—reply

Rachel L. Stewart; Kathleen L. O'Connor

doi:10.1016/j.humpath.2016.09.032

Integrin β4 is a controversial target for non–small cell lung cancer—reply

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	223-224
Number of pages	2
Journal	Human Pathology
Volume	61
DOIs	https://doi.org/10.1016/j.humpath.2016.09.032
State	Published - Mar 1 2017

ASJC Scopus subject areas

Pathology and Forensic Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.humpath.2016.09.032

Cite this

@article{3d98473b1e89414e8604828b0f1a7892,

title = "Integrin β4 is a controversial target for non–small cell lung cancer—reply",

author = "Stewart, \{Rachel L.\} and O'Connor, \{Kathleen L.\}",

year = "2017",

month = mar,

day = "1",

doi = "10.1016/j.humpath.2016.09.032",

language = "English",

volume = "61",

pages = "223--224",

}

TY - JOUR

T1 - Integrin β4 is a controversial target for non–small cell lung cancer—reply

AU - Stewart, Rachel L.

AU - O'Connor, Kathleen L.

PY - 2017/3/1

Y1 - 2017/3/1

UR - https://www.scopus.com/pages/publications/85011252782

UR - https://www.scopus.com/inward/citedby.url?scp=85011252782&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2016.09.032

DO - 10.1016/j.humpath.2016.09.032

M3 - Letter

C2 - 27816722

AN - SCOPUS:85011252782

SN - 0046-8177

VL - 61

SP - 223

EP - 224

JO - Human Pathology

JF - Human Pathology

ER -

Integrin β4 is a controversial target for non–small cell lung cancer—reply

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this